Challenges in Identifying Sentinel Lymph Nodes in Early Breast Cancer Patients: Should We Opt for Standard Axillary Lymph Node Dissection?
Journal of Breast Cancer · 2026 · 29 (3) · 248
DOI: 10.4048/jbc.2025.0193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Cancer, 2026. Verfasst von Jun Hyung Bang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pusan National University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
- Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea. seokwonlee@pusan.ac.kr.
ORCID-Profile: Jun Hyung Bang, Seokwon Lee
Förderung
- Pusan National University
Zitieren
APA
Bang, J. H., & Lee, S. (2026). Challenges in Identifying Sentinel Lymph Nodes in Early Breast Cancer Patients: Should We Opt for Standard Axillary Lymph Node Dissection?. Journal of Breast Cancer, 29(3), 248. https://doi.org/10.4048/jbc.2025.0193
Vancouver
Bang JH, Lee S. Challenges in Identifying Sentinel Lymph Nodes in Early Breast Cancer Patients: Should We Opt for Standard Axillary Lymph Node Dissection?. Journal of Breast Cancer. 2026;29(3):248. doi:10.4048/jbc.2025.0193
BibTeX
@article{Bang2026,
author = {Bang, Jun Hyung and Lee, Seokwon},
title = {Challenges in Identifying Sentinel Lymph Nodes in Early Breast Cancer Patients: Should We Opt for Standard Axillary Lymph Node Dissection?},
journal = {Journal of Breast Cancer},
year = {2026},
volume = {29},
number = {3},
pages = {248},
doi = {10.4048/jbc.2025.0193}
}
EUVIMED